Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    January 2017
  1. HOFFMAN SR, Le T, Lockhart A, Sanusi A, et al
    Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30623.
    PubMed     Text format    


  2. RODRIGUEZ AC, Avila C, Herrero R, Hildesheim A, et al
    Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30614.
    PubMed     Text format     Abstract available


  3. MITTAL S, Basu P, Muwonge R, Banerjee D, et al
    Risk of high grade precancerous lesions and invasive cancers in high risk HPV positive women with normal cervix or CIN 1 at baseline - a population based cohort study.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30609.
    PubMed     Text format     Abstract available


    December 2016
  4. WENTZENSEN N, Arbyn M, Berkhof J, Bower M, et al
    Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30579.
    PubMed     Text format     Abstract available


  5. HATANO T, Sano D, Takahashi H, Hyakusoku H, et al
    Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30589.
    PubMed     Text format     Abstract available


  6. BOGANI G, Chiappa V, Martinelli F, Raspagliesi F, et al
    Type-Specific HPV Infection Correlates with Risk of Recurrence of Vulvar Intraepithelial Neoplasia Usual Type.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30585.
    PubMed     Text format    


    November 2016
  7. KOCSIS A, Takacs T, Jeney C, Schaff Z, et al
    Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women: Subanalysis of the Ongoing Multicenter TRACE Clinical Trial (n>6,000) to Evaluate POU4F3 as a Potential Biomarker of Cervical Precancer and Cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30534.
    PubMed     Text format     Abstract available


  8. WAKEHAM K, Kavanagh K, Cuschieri K, Millan D, et al
    HPV status and favorable outcome in vulvar squamous cancer.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30523.
    PubMed     Text format     Abstract available


    October 2016
  9. SCHIFFMAN M, Yu K, Zuna R, Terence Dunn S, et al
    Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have >/=CIN2.
    Int J Cancer. 2016 Oct 1. doi: 10.1002/ijc.30456.
    PubMed     Text format     Abstract available


    September 2016
  10. OGILVIE GS, Krajden M, van Niekerk D, Smith LW, et al
    HPV For Cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid based cytology for cervical cancer.
    Int J Cancer. 2016 Sep 29. doi: 10.1002/ijc.30454.
    PubMed     Text format     Abstract available


  11. SUDENGA SL, Nelson Torres B, Fulp WJ, Silva R, et al
    Country-Specific HPV-related Genital Disease Among Men Residing in Brazil, Mexico, and the United States: The HIM Study.
    Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30452.
    PubMed     Text format     Abstract available


  12. KYRGIOU M, Kalliala I, Mitra A, Ng KY, et al
    Immediate referral to colposcopy vs. cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.
    Int J Cancer. 2016 Sep 7. doi: 10.1002/ijc.30419.
    PubMed     Text format     Abstract available


    August 2016
  13. SIMMS KT, Smith MA, Lew JB, Kitchener HC, et al
    Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
    Int J Cancer. 2016 Aug 19. doi: 10.1002/ijc.30392.
    PubMed     Text format     Abstract available


  14. GARLAND SM, Paavonen J, Jaisamrarn U, Naud P, et al
    Prior human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomised controlled trial.
    Int J Cancer. 2016 Aug 19. doi: 10.1002/ijc.30391.
    PubMed     Text format     Abstract available


  15. GARNAES E, Frederiksen K, Kiss K, Andersen L, et al
    Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30389.
    PubMed     Text format     Abstract available


  16. SCHIFFMAN M, Hyun N, Raine-Bennett TR, Katki H, et al
    A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30375.
    PubMed     Text format     Abstract available


    July 2016
  17. VON KNEBEL DOEBERITZ M
    The causal role of human papillomavirus infections in non-anogenital cancers. It's time to ask for the functional evidence.
    Int J Cancer. 2016;139:9-11.
    PubMed     Text format    


    June 2016
  18. BODELON C, Untereiner ME, Machiela MJ, Vinokurova S, et al
    Genomic characterization of viral integration sites in HPV-related cancers.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30243.
    PubMed     Text format     Abstract available


  19. DEPUYDT CE, Thys S, Beert J, Jonckheere J, et al
    Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30238.
    PubMed     Text format     Abstract available


  20. ZHAO FH, Hu SY, Zhang Q, Zhang X, et al
    Risk assessment to guide cervical screening strategies in a large Chinese population.
    Int J Cancer. 2016;138:2639-47.
    PubMed     Text format     Abstract available


    May 2016
  21. WAGNER S, Wittekindt C, Reuschenbach M, Hennig B, et al
    CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;138:2263-73.
    PubMed     Text format     Abstract available


    April 2016
  22. TANG A, Dadaglio G, Oberkampf M, Di Carlo S, et al
    B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer.
    Int J Cancer. 2016 Apr 30. doi: 10.1002/ijc.30169.
    PubMed     Text format     Abstract available


    March 2016
  23. FRANCESCHI S, Umulisa MC, Tshomo U, Gheit T, et al
    Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
    Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30092.
    PubMed     Text format     Abstract available


  24. EBISCH RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, et al
    The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
    Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30090.
    PubMed     Text format     Abstract available


    February 2016
  25. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    PubMed     Text format     Abstract available


  26. KINES RC, Cerio RJ, Roberts JN, Thompson CD, et al
    Human papillomavirus capsids preferentially bind and infect tumor cells.
    Int J Cancer. 2016;138:901-11.
    PubMed     Text format     Abstract available


  27. HERWEIJER E, Sundstrom K, Ploner A, Uhnoo I, et al
    Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
    Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30035.
    PubMed     Text format     Abstract available


  28. PETRY KU, Cox JT, Johnson K, Quint W, et al
    Evaluating HPV negative CIN2+ in the ATHENA trial.
    Int J Cancer. 2016 Feb 6. doi: 10.1002/ijc.30032.
    PubMed     Text format     Abstract available


  29. SULTANA F, English DR, Simpson JA, Drennan KT, et al
    Home-based HPV self-sampling improves participation by never- and under-screened women: Results from a large randomised trial (iPap) in Australia.
    Int J Cancer. 2016 Feb 6. doi: 10.1002/ijc.30031.
    PubMed     Text format     Abstract available


  30. BHATIA R, Kavanagh K, Cubie H, Serrano I, et al
    Use of HPV testing for cervical screening in vaccinated women - insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.
    Int J Cancer. 2016 Feb 4. doi: 10.1002/ijc.30030.
    PubMed     Text format     Abstract available


  31. WANG HM, Cheng NM, Lee LY, Fang YH, et al
    Heterogeneity of (18)F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma.
    Int J Cancer. 2016;138:731-8.
    PubMed     Text format     Abstract available


    January 2016
  32. LORINCZ AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, et al
    Validation of a DNA methylation HPV triage classifier in a screening sample.
    Int J Cancer. 2016 Jan 20. doi: 10.1002/ijc.30008.
    PubMed     Text format     Abstract available


  33. MOLIJN A, Jenkins D, Chen W, Zhang X, et al
    The complex relationship between human papillomavirus and cervical adenocarcinoma.
    Int J Cancer. 2016;138:409-16.
    PubMed     Text format     Abstract available


  34. VOJTECHOVA Z, Sabol I, Salakova M, Turek L, et al
    Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis.
    Int J Cancer. 2016;138:386-95.
    PubMed     Text format     Abstract available


  35. STENSEN S, Kjaer SK, Jensen SM, Frederiksen K, et al
    Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study.
    Int J Cancer. 2016;138:361-8.
    PubMed     Text format     Abstract available


  36. VAN BAARS R, van der Marel J, Snijders PJ, Rodriquez-Manfredi A, et al
    CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
    Int J Cancer. 2016;138:463-71.
    PubMed     Text format     Abstract available


  37. WANGSA D, Chowdhury SA, Ryott M, Gertz EM, et al
    Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.
    Int J Cancer. 2016;138:98-109.
    PubMed     Text format     Abstract available


    December 2015
  38. SKINNER SR, Wheeler CM, Romanowski B, Castellsague X, et al
    Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29971.
    PubMed     Text format     Abstract available


  39. FRANCESCHI S, Combes JD, Dalstein V, Caudroy S, et al
    Deep brush-based cytology in tonsils resected for benign diseases.
    Int J Cancer. 2015;137:2994-9.
    PubMed     Text format     Abstract available


  40. HOLL K, Nowakowski AM, Powell N, McCluggage WG, et al
    Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.
    Int J Cancer. 2015;137:2858-68.
    PubMed     Text format     Abstract available


  41. HAMMER A, Rositch A, Qeadan F, Gravitt PE, et al
    Age-specific prevalence of HPV16/18 genotypes in cervical cancer: a systematic review and meta-analysis.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29959.
    PubMed     Text format     Abstract available


    November 2015
  42. ZHANG F, Sturgis EM, Sun Y, Zhang Y, et al
    Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Int J Cancer. 2015;137:2454-61.
    PubMed     Text format     Abstract available


  43. FU TC, Fu Xi L, Hulbert A, Hughes JP, et al
    Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.
    Int J Cancer. 2015;137:2432-42.
    PubMed     Text format     Abstract available


  44. REICH O, Regauer S
    Two major pathways of recurrent high-grade squamous intraepithelial lesions of the cervix.
    Int J Cancer. 2015;137:2520-1.
    PubMed     Text format    


  45. HERFS M, Crum CP
    Response to "Two major pathways of recurrent high-grade squamous intraepithelial lesions of the cervix".
    Int J Cancer. 2015;137:2522-3.
    PubMed     Text format    


  46. CLIFFORD GM, Franceschi S, Keiser O, Schoni-Affolter F, et al
    Immunodeficiency and the risk of cervical intra-epithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV Cohort Study.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29913.
    PubMed     Text format     Abstract available


  47. HALEC G, Schmitt M, Egger S, Abnet CC, et al
    Mucosal Alpha-Papillomaviruses are not associated with Esophageal Squamous Cell Carcinomas: Lack of Mechanistic Evidence from South Africa, China and Iran and from a World-Wide Meta-Analysis.
    Int J Cancer. 2015 Nov 3. doi: 10.1002/ijc.29911.
    PubMed     Text format     Abstract available


    September 2015
  48. VALDEZ M, Jeronimo J, Bansil P, Qiao YL, et al
    Effectiveness of novel, lower-cost molecular human papillomavirus-based tests for cervical cancer screening in rural China.
    Int J Cancer. 2015 Sep 30. doi: 10.1002/ijc.29877.
    PubMed     Text format     Abstract available


  49. ZHANG R, Shen C, Zhao L, Wang J, et al
    Dysregulation of host cellular genes targeted by HPV integration contributes to HPV related cervical carcinogenesis.
    Int J Cancer. 2015 Sep 29. doi: 10.1002/ijc.29872.
    PubMed     Text format     Abstract available


    August 2015
  50. LUTTMER R, De Strooper LM, Berkhof J, Snijders PJ, et al
    Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Int J Cancer. 2015 Aug 28. doi: 10.1002/ijc.29824.
    PubMed     Text format     Abstract available


  51. LAPRISE C, Mathadil SA, Allison P, Abraham P, et al
    No role for human papillomavirus infection in oral cancers in a region in Southern India.
    Int J Cancer. 2015 Aug 28. doi: 10.1002/ijc.29827.
    PubMed     Text format     Abstract available


  52. CHUNG TK, Van Hummelen P, Chan PK, Cheung TH, et al
    Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women.
    Int J Cancer. 2015;137:776-83.
    PubMed     Text format     Abstract available


    July 2015
  53. HEIDENREICH R, Jasny E, Kowalczyk A, Lutz J, et al
    A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
    Int J Cancer. 2015;137:372-84.
    PubMed     Text format     Abstract available


  54. BALERMPAS P, Rodel F, Rodel C, Krause M, et al
    CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29683.
    PubMed     Text format     Abstract available


  55. GOSVIG CF, Huusom LD, Andersen KK, Duun-Henriksen AK, et al
    Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization.
    Int J Cancer. 2015 Jul 2. doi: 10.1002/ijc.29673.
    PubMed     Text format     Abstract available


  56. THOMSEN LT, Frederiksen K, Munk C, Junge J, et al
    Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
    Int J Cancer. 2015;137:193-203.
    PubMed     Text format     Abstract available


  57. RANIERI D, Belleudi F, Magenta A, Torrisi MR, et al
    HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.
    Int J Cancer. 2015;137:61-72.
    PubMed     Text format     Abstract available


    June 2015
  58. WICHMANN G, Rosolowski M, Krohn K, Kreuz M, et al
    The role of HPV RNA transcription, immune response- related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
    Int J Cancer. 2015 Jun 20. doi: 10.1002/ijc.29649.
    PubMed     Text format     Abstract available


  59. CUZICK J, Myers O, Hunt WC, Saslow D, et al
    Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.
    Int J Cancer. 2015;136:2854-63.
    PubMed     Text format     Abstract available


  60. HOLLOWAY A, Simmonds M, Azad A, Fox JL, et al
    Resistance to UV-induced apoptosis by beta-HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase.
    Int J Cancer. 2015;136:2831-43.
    PubMed     Text format     Abstract available


  61. BERGERON C, Ronco G, Reuschenbach M, Wentzensen N, et al
    The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.
    Int J Cancer. 2015;136:2741-51.
    PubMed     Text format     Abstract available


    May 2015
  62. CAMPOS NG, Castle PE, Wright TC, Kim JJ, et al
    Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
    Int J Cancer. 2015 May 5. doi: 10.1002/ijc.29594.
    PubMed     Text format     Abstract available


    April 2015
  63. GAYKALOVA DA, Manola JB, Ozawa H, Zizkova V, et al
    NF-kappaB and STAT3 transcription factor signatures differentiate HPV-positive and HPV-negative Head and neck squamous cell carcinoma.
    Int J Cancer. 2015 Apr 9. doi: 10.1002/ijc.29558.
    PubMed     Text format     Abstract available


  64. LONNBERG S, Hansen BT, Haldorsen T, Campbell S, et al
    Cervical cancer prevented by screening: Long-term incidence trends by morphology in Norway.
    Int J Cancer. 2015 Apr 1. doi: 10.1002/ijc.29541.
    PubMed     Text format     Abstract available


    March 2015
  65. ARROSSI S, Thouyaret L, Laudi R, Marin O, et al
    Implementation of HPV-testing for cervical cancer screening in programmatic contexts: The Jujuy demonstration project in Argentina.
    Int J Cancer. 2015 Mar 24. doi: 10.1002/ijc.29530.
    PubMed     Text format     Abstract available


  66. OGILVIE GS, Naus M, Money DM, Dobson SR, et al
    Reduction in cervical dysplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.
    Int J Cancer. 2015 Mar 6. doi: 10.1002/ijc.29508.
    PubMed     Text format     Abstract available


    January 2015
  67. BASU P, Mittal S, Banerjee D, Singh P, et al
    Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a Cervical Cancer Screening Demonstration Project in India.
    Int J Cancer. 2015 Jan 28. doi: 10.1002/ijc.29458.
    PubMed     Text format     Abstract available


  68. CAMPOS NG, Maza M, Alfaro K, Gage JC, et al
    The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
    Int J Cancer. 2015 Jan 14. doi: 10.1002/ijc.29438.
    PubMed     Text format     Abstract available


  69. VERDOODT F, Jiang X, Williams M, Schnatz PF, et al
    High-risk HPV testing in the management of atypical glandular cells: a systematic review and meta-analysis.
    Int J Cancer. 2015 Jan 12. doi: 10.1002/ijc.29424.
    PubMed     Text format     Abstract available


    December 2014
  70. VINK MA, Bogaards JA, Meijer CJ, Berkhof J, et al
    Primary human papillomavirus (HPV) DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
    Int J Cancer. 2014 Dec 6. doi: 10.1002/ijc.29381.
    PubMed     Text format     Abstract available


    November 2014
  71. BIGONI J, Gundar M, Tebeu PM, Bongoe A, et al
    Cervical cancer screening in sub-Saharan Africa: A randomised trial of VIA vs cytology for triage of HPV-positive women.
    Int J Cancer. 2014 Nov 24. doi: 10.1002/ijc.29353.
    PubMed     Text format     Abstract available


  72. KLINGHAMMER K, Raguse JD, Plath T, Albers AE, et al
    A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
    Int J Cancer. 2014 Nov 18. doi: 10.1002/ijc.29344.
    PubMed     Text format     Abstract available


  73. HWANG TZ, Hsiao JR, Tsai CR, Chang JS, et al
    Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.
    Int J Cancer. 2014 Nov 14. doi: 10.1002/ijc.29330.
    PubMed     Text format     Abstract available


    September 2014
  74. CHEN H, Chen XZ, Waterboer T, Castro FA, et al
    Viral infections and colorectal cancer: A systematic review of epidemiological studies.
    Int J Cancer. 2014 Sep 4. doi: 10.1002/ijc.29180.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: